Ardelyx (ARDX) Change in Cash (2013 - 2026)
Ardelyx posted quarterly Change in Cash of -$36.8 million for Q1 2026, down 7.81% year-on-year from -$39.9 million in Q1 2025, and down 245.51% on a QoQ basis from $25.3 million in Q4 2025.
Ardelyx (ARDX) has 14 years of Change in Cash data on file, last reported at -$36.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 7.81% year-over-year to -$36.8 million; the trailing twelve-month figure through Mar 2026 stood at $401000.0 (up 107.51% YoY), and the FY2025 full-year result was $3.1 million, down 92.94% from the prior year.
- Change in Cash for Q1 2026 stood at -$36.8 million, down from $25.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $59.2 million in Q2 2025 and bottomed at -$62.4 million in Q2 2023.
- The 5-year median for Change in Cash is $5.5 million (2024), against an average of -$2.4 million.
- The widest annual swing landed in 2022, when Change in Cash soared 1306.71%; it then slumped 1086.08% in 2023.
- A 5-year view of Change in Cash shows it stood at $34.5 million in 2022, then sank by 135.63% to -$12.3 million in 2023, then surged by 242.34% to $17.5 million in 2024, then soared by 44.46% to $25.3 million in 2025, then slumped by 245.51% to -$36.8 million in 2026.
- The last three Change in Cash figures came in at -$36.8 million (Q1 2026), $25.3 million (Q4 2025), and -$47.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -36.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.79 Mn |
| Dec 31, 2025 | 25.28 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Jun 30, 2025 | 59.24 Mn |
| Mar 31, 2025 | -34.12 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 5.74 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | -12.30 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | -62.43 Mn |
| Mar 31, 2023 | -3.65 Mn |
| Dec 31, 2022 | 34.51 Mn |
| Sep 30, 2022 | 8.22 Mn |
| Jun 30, 2022 | 6.33 Mn |
| Mar 31, 2022 | -25.35 Mn |
| Dec 31, 2021 | -2.86 Mn |
| Sep 30, 2021 | -11.46 Mn |
| Jun 30, 2021 | 2.68 Mn |
| Mar 31, 2021 | -6.96 Mn |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | -9.49 Mn |
| Jun 30, 2020 | -5.40 Mn |
| Mar 31, 2020 | -75.24 Mn |
| Dec 31, 2019 | 88.46 Mn |
| Sep 30, 2019 | 3.05 Mn |
| Jun 30, 2019 | -2.41 Mn |
| Mar 31, 2019 | 13.27 Mn |
| Dec 31, 2018 | 3.75 Mn |
| Sep 30, 2018 | -16.74 Mn |
| Jun 30, 2018 | 24.01 Mn |
| Mar 31, 2018 | -7.64 Mn |
| Dec 31, 2017 | 15.93 Mn |
| Sep 30, 2017 | -4.18 Mn |
| Jun 30, 2017 | -7.58 Mn |
| Mar 31, 2017 | -3.39 Mn |
| Dec 31, 2016 | -85.76 Mn |
| Sep 30, 2016 | 13.69 Mn |
| Jun 30, 2016 | -25.01 Mn |
| Mar 31, 2016 | 64.67 Mn |
| Dec 31, 2015 | -22.04 Mn |
| Sep 30, 2015 | -12.49 Mn |
| Jun 30, 2015 | 43.22 Mn |
| Mar 31, 2015 | -8.97 Mn |
| Dec 31, 2014 | -4.76 Mn |
| Sep 30, 2014 | -5.77 Mn |
| Jun 30, 2014 | 84.59 Mn |
| Mar 31, 2014 | -1.21 Mn |
| Dec 31, 2013 | 10.91 Mn |
| Sep 30, 2013 | -221,000.00 |